Format

Send to

Choose Destination
Eur J Neurosci. 2019 Jan 28. doi: 10.1111/ejn.14356. [Epub ahead of print]

Cerebrospinal fluid flow dynamics in Huntington's disease evaluated by phase contrast MRI.

Author information

1
UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
2
Neuroradiological Academic Unit, UCL Queen Square Institute of Neurology, University College London, London, UK.
3
Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
4
Ixico Plc, London, UK.

Abstract

Multiple targeted therapeutics for Huntington's disease are now in clinical trials, including intrathecally delivered compounds. Previous research suggests that CSF dynamics may be altered in Huntington's disease, which could be of paramount relevance to intrathecal drug delivery to the brain. To test this hypothesis, we conducted a prospective cross-sectional study comparing people with early stage Huntington's disease with age- and gender-matched healthy controls. CSF peak velocity, mean velocity and mean flow at the level of the cerebral aqueduct, and sub-arachnoid space in the upper and lower spine, were quantified using phase contrast MRI. We calculated Spearman's rank correlations, and tested inter-group differences with Wilcoxon rank-sum test. Ten people with early Huntington's disease, and 10 controls were included. None of the quantified measures was associated with potential modifiers of CSF dynamics (demographics, osmolality, and brain volumes), or by known modifiers of Huntington's disease (age and HTTCAG repeat length); and no significant differences were found between the two studied groups. While external validation is required, the attained results are sufficient to conclude tentatively that a clinically relevant alteration of CSF dynamics - that is, one that would justify dose-adjustments of intrathecal drugs - is unlikely to exist in Huntington's disease.

KEYWORDS:

Huntington disease; cerebrospinal fluid; humans; magnetic resonance imaging

PMID:
30687961
DOI:
10.1111/ejn.14356

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center